Crop Life Science Limited has approved an additional Working Capital Term Loan of ₹7.96 crore from HDFC Bank under the Emergency Credit Line Guarantee Scheme (ECLGS) 5.0. The Board of Directors sanctioned the borrowing during a meeting held on June 03, 2026, at the company's registered office to bolster its liquidity position.

The approval was part of the agenda discussed at the board meeting, which commenced at 05:00 PM and concluded at 06:00 PM. The decision aligns with the company's strategy to utilize available government-backed credit facilities to strengthen its financial health.

Key Details of the Approval

The resolution passed by the board specifically pertains to the availing of funds under the ECLGS 5.0 framework. This scheme is designed to provide emergency credit support to businesses, aiding in the recovery of economic disruptions.

The disclosure was submitted to the National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rajeshkumar Vrajlal Lunagariya, Managing Director, signed the filing on behalf of the company.

Crop Life Science Limited reported a net profit of ₹698.69 lakh for the financial year ended March 31, 2026, an increase from ₹662.03 lakh in the previous year. Revenue from operations rose to ₹20,717.42 lakh for FY26, compared to ₹20,059.00 lakh in FY25. The company’s basic and diluted earnings per share stood at ₹4.08 for the year, up from ₹3.86 in the prior year.

The Board of Directors approved the audited standalone and consolidated financial statements for the half year and year ended March 31, 2026, at its meeting held on May 26, 2026. Shah & Shah, Chartered Accountants, issued an audit report with an unmodified opinion on the financial results. The statutory auditors confirmed that the results give a true and fair view in conformity with the Indian Accounting Standards.

Standalone Financial Performance

For the year ended March 31, 2026, total income stood at ₹20,888.52 lakh, a slight increase from ₹20,157.16 lakh in the previous year. Total expenses for the period were ₹19,904.37 lakh, compared to ₹19,256.08 lakh in FY25. The profit before exceptional items was ₹984.15 lakh, while exceptional items for the year amounted to ₹6.28 lakh.

Consolidated Financial Results

On a consolidated basis, the company reported a net profit of ₹649.49 lakh for FY26, up from ₹560.11 lakh in the previous year. Total consolidated revenue from operations was ₹20,717.42 lakh, matching the standalone figures. Profit attributable to the owners of the company stood at ₹663.51 lakh, while non-controlling interest was recorded at a loss of ₹14.02 lakh.

Financial Position and Cash Flows

The total assets of the company stood at ₹20,531.69 lakh as of March 31, 2026, up from ₹17,770.69 lakh in the previous year. Total equity increased to ₹8,534.52 lakh from ₹7,820.18 lakh. The net cash flow from operating activities was negative at ₹(791.45) lakh, primarily due to changes in working capital. The company reported a net increase in cash and cash equivalents of ₹1,555.31 lakh during the year.